Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1965 Nov;24(6):572–575. doi: 10.1136/ard.24.6.572

Effect of atromid and its components on uric acid excretion and on gout.

G Trevaks, R R Lovell
PMCID: PMC1010409  PMID: 5855251

Full text

PDF
572

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FASOLI A., CESANA A. SERUM LIPID AND LIPOPROTEIN CHANGES AFTER TREATMENT WITH ATROMID IN PATIENTS WITH ATHEROSCLEROSIS, ESSENTIAL HYPERLIPAEMIA AND FAMILIAL HYPERCHOLESTEROLAEMIA. J Atheroscler Res. 1963 Sep-Dec;3:475–481. doi: 10.1016/s0368-1319(63)80027-7. [DOI] [PubMed] [Google Scholar]
  2. GREEN K. G., INMAN W. H., THORP J. M. MULTICENTRE TRIAL IN THE UNITED KINGDOM AND IRELAND OF A MIXTURE OF ETHYL CHLOROPHENOXYISOBUTYRATE AND ANDROSTERONE (ATROMID). A PRELIMINARY REPORT. J Atheroscler Res. 1963 Sep-Dec;3:593–616. doi: 10.1016/s0368-1319(63)80043-5. [DOI] [PubMed] [Google Scholar]
  3. HARE R. S. Endogenous creatinine in serum and urine. Proc Soc Exp Biol Med. 1950 May;74(1):148–151. doi: 10.3181/00379727-74-17837. [DOI] [PubMed] [Google Scholar]
  4. HELLMAN L., ZUMOFF B., KESSLER G., KARA E., RUBIN I. L., ROSENFELD R. S. REDUCTION OF CHOLESTEROL AND LIPIDS IN MAN BY ETHYL P-CHLOROPHENOXYISOBUTYRATE. Ann Intern Med. 1963 Oct;59:477–494. doi: 10.7326/0003-4819-59-4-477. [DOI] [PubMed] [Google Scholar]
  5. HOWARD R. P., ALAUPOVIC P., BRUSCO O. J., FURMAN R. H. EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN NORMAL AND HYPERLIPIDEMIC SUBJECTS. J Atheroscler Res. 1963 Sep-Dec;3:482–499. doi: 10.1016/s0368-1319(63)80028-9. [DOI] [PubMed] [Google Scholar]
  6. JEPSON E. M., JAMES D. C. THE TREATMENT OF HYPERCHOLESTEROLAEMIC XANTHOMATOSIS WITH ATROMID. J Atheroscler Res. 1963 Sep-Dec;3:554–560. doi: 10.1016/s0368-1319(63)80037-x. [DOI] [PubMed] [Google Scholar]
  7. LIDDLE L., SEEGMILLER J. E., LASTER L. The enzymatic spectrophotometric method for determination of uric acid. J Lab Clin Med. 1959 Dec;54:903–913. [PubMed] [Google Scholar]
  8. OGRYZLO M. A., HARRISON J. Evaluation of uricosuric agents in chronic gout. Ann Rheum Dis. 1957 Dec;16(4):425–437. doi: 10.1136/ard.16.4.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. OLIVER M. F. Reduction of serum-lipid and uric-acid levels by an orally active androsterone. Lancet. 1962 Jun 23;1(7243):1321–1323. doi: 10.1016/s0140-6736(62)92422-4. [DOI] [PubMed] [Google Scholar]
  10. YU T. F., GUTMAN A. B. Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest. 1959 Aug;38(8):1298–1315. doi: 10.1172/JCI103905. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES